Neuropace Inc (NPCE)

EBITDA Margin

-18.10%

Quarterly · Period ending:

NPCE logo

NPCE EBITDA Margin

Latest reported-18.10%
NPCE Quarterly EBITDA Margin (-36.70% → -18.10%)
High-resolution chart · PNG

NPCE ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neuropace Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-18.0978%
-21.0939%
-2.283%
-7.4249%
-25.9991%
-17.6434%
-12.1448%
-13.3856%
-25.4674%
-34.4516%
-19.7368%
-28.4166%
-39.9515%
-55.3828%
-66.0959%
-81.9217%
-98.9608%
-78.064%
-79.5853%
-59.793%
-51.8844%
-61.3979%
-24.7768%
-9.6625%
-64.1099%
-36.7018%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.